EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics
EpiVax, Inc. a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate,…
Read More...
Read More...
